Author

Morgane Perdomini

Observed names: M Perdomini, M. Perdomini

Observed institutions: Université Paris-Sud, Boston Children's Hospital, Centre National de la Recherche Scientifique, Harvard University, Inserm, Collège de France, Université Paris-Saclay, Institut de génétique et de biologie moléculaire et cellulaire, MedDay (France), Institut de Biologie Moléculaire et Cellulaire, Manton Center for Orphan Disease Research, Université de Strasbourg

OpenAlex ID: A5072083524

Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia

2014 · Morgane Perdomini, Brahim Belbellaa, et al. · Nature Medicine · 252

Animal and cellular models of Friedreich ataxia

2013 · Morgane Perdomini, Aurore Hick, et al. · Journal of Neurochemistry · 92

An AAVrh10-CAG-CYP21-HA vector allows persistent correction of 21-hydroxylase deficiency in a Cyp21−/− mouse model

2017 · M Perdomini, C Dos Santos, et al. · Gene Therapy · 37

Phenotypic Spectrum of DNM2 -Related Centronuclear Myopathy

2022 · Leslie Hotchkiss Hayes, Morgane Perdomini, et al. · Neurology Genetics · 17

PEMDA-HN, an open-label, phase II, randomized controlled study of danvatirsen plus pembrolizumab compared to pembrolizumab alone in first-line recurrent and/or metastatic head and neck squamous cell carcinoma (RM HNSCC).

2024 · Marshall R. Posner, Deborah J.L. Wong, et al. · Journal of Clinical Oncology · 2

943TiP PEMDA-HN, an open-label, phase II, randomized controlled study of danvatirsen plus pembrolizumab compared to pembrolizumab alone in recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC)

2023 · N. Saba, H. Youssoufian, et al. · Annals of Oncology

High Dose Biotin, MD1003, Protects Axons in a Mouse Model of Chronic Spinal Cord Demyelination (P2.2-057)

2019 · Arthur Warrington, Morgane Perdomini, et al. · Neurology

AAV Gene Therapy of 21-Hydroxylase Deficiency (21OHD) in Cyp21−/− mice

2016 · Morgane Perdomini, Christine Menguy-Dos Santos, et al. · 55th ESPE Meeting

0300: Systemic delivery of AAVrh10 expressing frataxin corrects the severe mitochondrial cardiomyopathy of frataxin deficient mice

2014 · Brahim Belbellaa, Morgane Perdomini, et al. · Archives of Cardiovascular Diseases Supplements

Développement d'une thérapie génique dans le modèle murin cardiaque de l'ataxie de Friedreich en utilisant le vecteur adéno-associé rAAVrh10

2013 · Morgane Perdomini · theses.fr (ABES)

Works count: 10

Citation count: 400

H-index: 4

I10-index: 4